look news india
FII stake in the company has increased rapidly during the September quarter. According to the data, FII stake in the company increased to 7.52 percent at the end of September quarter, which was 5.59 percent at the end of June quarter. This stock has given a return of 75 percent in the last one year. However, the stock has fallen 13 percent in 3 months.
Glenmark Pharma
FIIs bought shares in Glenmark Pharma in September. According to the data at the end of September quarter, compared to June quarter, FII stake in the company has increased from 20.98 percent to 23.05 percent. Notably, FIIs were selling stocks till the June quarter and by the end of the first quarter FII holdings were at their lowest level in a year, however, FII holdings once again increased in September. Quarterly shares have given returns of 97 percent so far in 2024.
FII stake in Lupine is continuously increasing. By the end of the September quarter, FII stake in the company has increased to 21.5 percent. Which was 19.32 percent by the end of June 2024, 18.29 percent by the end of March 2024 and 16.11 percent by the end of December 2023. The stock is up 57 percent so far in 2024, while the stock is down about 5 percent in a month.
Know in which companies FIIA increased participation –
If we look at the holdings of FIIs in the second quarter as compared to the first quarter, the holdings in Laurel Labs have increased from 25.67 percent to 26.08 percent, in Biocon from 5.9 percent to 5.93 percent. Holdings in Torrent Pharma increased from 14.22 percent to 14.46 percent, in Netco Pharma increased from 17.45 percent to 17.51 percent, in Cipla increased from 27.82 percent to 17.25 percent, in Manakin increased from 17.25 percent to 11.58 percent, in Sun Pharma increased from 17.25 percent to 37 percent. It increased from 17.23 percent to 18.01 percent in Lab and from 8.69 percent to 9.02 percent in Alkem Lab.